Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DR26F9AS5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,646
Award facts
- Contract value 100% obligated
- $14,646.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 count) on November 7, 2025, with a ceiling value of $14,646.39 and an ultimate completion date of November 10, 2025. The contract employs firm fixed pricing and represents a non-competitive, non-set-aside delivery order. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $1 billion through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience fulfilling DLA requirements across multiple therapeutic domains. The contractor's portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies supporting military and veteran healthcare systems. The SPE2DX contract represents a prime vehicle under the DLA Troop Support Medical Supply Chain, positioning AmerisourceBergen as a key supplier for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with anticipated multiple awards across regions, demonstrating ongoing reliance on established contractors like AmerisourceBergen for federal pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DR26F9AS5?
SPE2DR26F9AS5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F9AS5 worth?
The government has obligated $14,646 on SPE2DR26F9AS5.
Is contract SPE2DR26F9AS5 an order under another contract?
Yes. SPE2DR26F9AS5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AS5 competed?
The extent of competition for SPE2DR26F9AS5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award